4:02 AM
 | 
Oct 05, 2017
 |  BC Extra  |  Financial News

Visterra tops off series C round

Anti-infectives company Visterra Inc. (Cambridge, Mass.) raised $23.6 million in an extension of a series C round, bringing the round's total to $46.7 million. Visterra raised an initial $23.1 million close in June...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >